Trial Search Results

Characterization of Treatment Responses in Lymphedema

This study is designed to investigate the treatment response of lymphedema, of the upper or lower extremity, during clinical, pharmacologic treatment of lymphedema with oral ketoprofen. Correlation of clinical responses (changes in limb volume and skin thickness) with changes in the inflammasome will help to define the molecular substrate of treatment response.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):

Intervention(s):

  • Drug: Ketoprofen

Eligibility


Inclusion Criteria:

   - Participants with a history of acquired lymphedema

   - Stage 1, 2, or 3

   - 18-75 years

   - Clinical use of ketoprofen for lymphedema

Exclusion Criteria:

   - Active cancer, infection, bleeding tendency, inflammatory disease and/or taking
   anti-inflammatory medication will be excluded.

   - Pregnant or lactating females

   - Inability to take ketoprofen (contra-indicated, e.g patients with known CV, GI, renal,
   hepatic disease).

Ages Eligible for Study

18 Years - 75 Years

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Leslie Roche, BSN
6507231396
Not Recruiting